HomeDVAX • NASDAQ
add
Dynavax Technologies Corp
Previous close
$10.62
Day range
$10.64 - $10.81
Year range
$9.22 - $14.63
Market cap
1.27B USD
Avg Volume
1.46M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 95.44M | 29.33% |
Operating expense | 61.92M | 20.17% |
Net income | 18.72M | 64.42% |
Net profit margin | 19.61 | 27.09% |
Earnings per share | 0.19 | 139.50% |
EBITDA | 17.90M | 109.62% |
Effective tax rate | 11.76% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 613.73M | -16.57% |
Total assets | 918.45M | -9.63% |
Total liabilities | 424.29M | 13.61% |
Total equity | 494.16M | — |
Shares outstanding | 117.27M | — |
Price to book | 2.52 | — |
Return on assets | 4.47% | — |
Return on capital | 5.19% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | 18.72M | 64.42% |
Cash from operations | 23.43M | 118.72% |
Cash from investing | 94.79M | 429.52% |
Cash from financing | -71.92M | -4,982.54% |
Net change in cash | 47.40M | 342.69% |
Free cash flow | 14.55M | 190.50% |
About
CEO
Founded
1996
Headquarters
Website
Employees
405